2016. Myocardial salvaging effects and mechanisms of dipeptidyl peptidase-IV inhibitor Vildagliptin in experimental diabetes. International Journal of Biomedical Research. 7, 5 (May 2016), 276–282. DOI:https://doi.org/10.7439/ijbr.v7i5.3273.